Polypharmacy in Nursing Homes

Elaine Roh; Esteban Cota; Jason P Lee; Ruth Madievsky; Manuel A Eskildsen

doi:10.1016/j.cger.2022.05.007

Polypharmacy in Nursing Homes

Clin Geriatr Med. 2022 Nov;38(4):653-666. doi: 10.1016/j.cger.2022.05.007. Epub 2022 Sep 11.

Authors

Elaine Roh¹, Esteban Cota², Jason P Lee², Ruth Madievsky³, Manuel A Eskildsen⁴

Affiliations

¹ Department of Internal Medicine, Division of Geriatrics, University of California, 10945 Le Conte Avenue, Suite 2339, Los Angeles, CA 90095, USA.
² Department of Geriatric Psychiatry, University of California, 760 Westwood Plaza, Los Angeles, CA 90095, USA.
³ Division of General Internal Medicine & Health Services Research, University of California, 1100 Glendon Avenue, Suite 850, Los Angeles, CA 90024, USA.
⁴ Department of Internal Medicine, Division of Geriatrics, University of California, 10945 Le Conte Avenue, Suite 2339, Los Angeles, CA 90095, USA. Electronic address: meskildsen@mednet.ucla.edu.

PMID: 36210082
DOI: 10.1016/j.cger.2022.05.007

Abstract

Older adults in the nursing home are at high risk for polypharmacy. This article provides a background of older adults in nursing homes and reviews key steps to address polypharmacy.

Keywords: Adverse drug events/reactions; Deprescribing; Drug–drug interactions; Frail; Nursing home; Potentially inappropriate medications.

Publication types

Review

MeSH terms

Aged
Humans
Inappropriate Prescribing
Nursing Homes*
Polypharmacy*